Intrinsiqs

Is Century Therapeutics, Inc. overvalued?

Century Therapeutics, Inc. (IPSC) — key valuation metrics and fundamentals.

No verdict
Price
$1.92
Fair value
Current P/E
Normal P/E
Market cap
$166.2M
Dividend yield
0.0%
Return on equity
-53.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IPSC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.